The Archives

Everything written by Ashwin Varma on law, economics, and more

Ashwin Varma

Ashwin Varma is a third-year medical student at the University of Texas Health Science Center at San Antonio with an interest in biopharmaceutical development and economics. Prior to attending medical school, Ashwin was a former associate consultant at Boston Consulting Group, where he focused on work related to COVID-19 drug development, and previously worked in Business Development at Celgene.

Posts

FTC v Amgen: The Economics of Bundled Discounts, Part Two

Ashwin Varma Jun 09, 2023

The Federal Trade Commission (FTC) recently announced that it would sue to block Amgen’s proposed $27.8 billion acquisition of Horizon Therapeutics. The challenge represents a landmark in the history of pharmaceutical-industry antitrust enforcement, as the industry has largely been given license to engage in permissive mergers and acquisitions of smaller companies without challenge. In Part One, ... FTC v Amgen: The Economics of Bundled Discounts, Part Two

AntitrustConsumer Welfare StandardExclusionary Conduct

FTC v Amgen: The Economics of Bundled Discounts, Part One

Ashwin Varma Jun 08, 2023

The Federal Trade Commission (FTC) recently announced that it would seek to block Amgen’s proposed $27.8 billion acquisition of Horizon Therapeutics. The move was the culmination of several years’ worth of increased scrutiny from both Congress and the FTC into antitrust issues in the biopharmaceutical industry. While the FTC’s move didn’t elicit much public comment, ... FTC v Amgen: The Economics of Bundled Discounts, Part One

AntitrustExclusionary ConductFTC